Skip to content

Supraventricular Tachycardia Collection Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02158728
Enrollment
80
Registered
2014-06-09
Start date
2014-06-30
Completion date
2015-10-31
Last updated
2017-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Supraventricular Arrhythmias

Brief summary

To collect supraventricular tachycardia (SVT) data for developing and testing sensing and detection algorithms for a subcutaneous implantable cardioverter defibrillator (ICD).

Detailed description

The purpose of the SVT Collect study is to collect supraventricular tachycardia episode data for developing and testing new sensing and detection algorithms for a future subcutaneous ICD.

Interventions

None listed

Sponsors

Medtronic Cardiac Rhythm and Heart Failure
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects aged 18 or above, or of legal age to give consent specific to the national law of the countries in which the trial is being conducted * Subjects indicated for implantable cardioverter defibrillator (ICD)/cardiac resynchronization therapy defibrillator (CRT-D) implant or ICD/CRT-D change-out, OR subjects indicated for an ICD/CRT-D that are undergoing ablation or electrophysiology (EP) study (including Non-invasive EP Study \[NIPS\]) * Subjects are willing to provide Informed Consent

Exclusion criteria

* Subjects who are ventricular pacing dependent * Subjects with a preexisting dual/triple chamber pacemaker or ICD who have a history of atrioventricular (AV) block with atrial pacing \< 120 beats per minute (BPM) while awake. * Subjects who are unable to tolerate elevated ventricular rates (≥170BPM) * Any condition which precludes the subject's ability to comply with the study requirements * Enrollment in a concurrent study (without prior study management approval) that may confound the results of this study * Subjects who are legally incompetent * Subjects meet

Design outcomes

Primary

MeasureTime frameDescription
Number of Electrocardiograms (ECGs) CollectedAfter recorded ECGs had been received, which were collected until the end of the indicated procedureCollected were the number of ECGs received from the enrolled subjects, the number of ECGs with SVT (supraventricular tachycardia) episodes, and the number of ECGs with SVT episodes qualified for algorithm development and validation of the potential new ICD. The ECG data were collected continuously during the indicated procedure (ICD/CRT-D implant, ICD/CRT-D change-out, electrophysiology (EP) study (including non invasive EP study)

Countries

Hungary

Participant flow

Participants by arm

ArmCount
ICD Indicated Subjects
Subjects indicated for implantable cardioverter defibrillator (ICD)/cardiac resynchronization therapy defibrillator (CRT-D) implant, ICD/CRT-D change-out, or indicated for an ICD/CRT-D and undergoing ablation or electrophysiology (EP) study (including Non-Invasive ElectroPhysiology Study \[NIPS\]).
53
Total53

Withdrawals & dropouts

PeriodReasonFG000
Overall Studyno procedure according to CIP done3
Overall Studyno qualified dataset24

Baseline characteristics

CharacteristicICD Indicated Subjects
Age, Continuous57 years
STANDARD_DEVIATION 14
Atrial arrhythmias15 participants
Congestive Heart Failure31 participants
Coronary Artery Disease24 participants
Hypertension25 participants
Indication for cardiac resynchronization therapy defibrillator (CRT-D)6 participants
Indication for implantable cardioverter defibrillator (ICD)47 participants
Previous myocardial infarction17 participants
Region of Enrollment
China
2 participants
Region of Enrollment
Hong Kong
11 participants
Region of Enrollment
Hungary
6 participants
Region of Enrollment
Slovakia
13 participants
Region of Enrollment
Taiwan
21 participants
Sex: Female, Male
Female
16 Participants
Sex: Female, Male
Male
37 Participants
Sinus arrhythmias13 participants
Sinus atrioventricular (AV) junctional arrhythmias and blocks23 participants
Ventricular arrhythmias42 participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 80
serious
Total, serious adverse events
0 / 80

Outcome results

Primary

Number of Electrocardiograms (ECGs) Collected

Collected were the number of ECGs received from the enrolled subjects, the number of ECGs with SVT (supraventricular tachycardia) episodes, and the number of ECGs with SVT episodes qualified for algorithm development and validation of the potential new ICD. The ECG data were collected continuously during the indicated procedure (ICD/CRT-D implant, ICD/CRT-D change-out, electrophysiology (EP) study (including non invasive EP study)

Time frame: After recorded ECGs had been received, which were collected until the end of the indicated procedure

Population: Total number of ECGs received from the 80 enrolled subjects.

ArmMeasureGroupValue (NUMBER)
ICD Indicated SubjectsNumber of Electrocardiograms (ECGs) CollectedNumber of ECGs received77 ECG
ICD Indicated SubjectsNumber of Electrocardiograms (ECGs) CollectedNumber of ECGs with SVT episodes67 ECG
ICD Indicated SubjectsNumber of Electrocardiograms (ECGs) CollectedNumber of ECGs with qualified SVT episodes53 ECG

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026